The Joint Corp.

What they do

The Joint franchises and operates chiropractic clinics offering appointment-free adjustments in an open-bay retail setting, priced below most insurance co-payments. Franchisees collect royalties of 7.0% of gross sales plus a 2.0% national marketing fee, and pay an initial franchise fee of $39,900, with regional developers receiving up to 50% of franchise fees and a 3.0% royalty. As of June 30, 2026, the network had 941 clinics, of which 896 were franchised and 45 company-owned or managed.

Revenue drivers

• Royalty and marketing fees from franchised clinics — Franchised clinics pay 7.0% of gross sales as royalty and 2.0% as national marketing fee; franchisees operated 896 of 941 clinics as of June 30, 2026, making this the largest revenue source.
• Initial franchise fees and regional developer fees — The company collects $39,900 per directly sold franchise, with discounts for veterans and multi-unit buyers; regional developers typically receive up to 50% of the franchise fee for licenses sold through their network.
• Company-owned or managed clinics — As of June 30, 2026, 45 clinics were company-owned or managed, a shrinking segment as the company refranchises its corporate portfolio, with total revenue from continuing operations of $15.2 million in Q2 2026.
• IT and other franchise-related revenue — IT cost of revenues was $1.7 million in 2025, and other franchisee-paid fees such as computer software fees support the franchise system.

Recent performance

For the second quarter of 2026, revenue from continuing operations grew 14% to $15.2 million, while system-wide sales across all clinics decreased 3.7% to $180.0 million and comp sales declined 2.8%. Net income from consolidated operations was $653,000 versus $93,000 in Q2 2025, while net loss from continuing operations narrowed to $251,000 from $1.0 million. Adjusted EBITDA from continuing operations rose to $1.5 million from $88,000. Cash flow from operating activities improved 152% to $2.2 million, and free cash flow was $1.9 million. For full-year 2025, revenue was $54.9 million, net income was $2.9 million, and operating cash flow was $1.8 million.

Strategy

The company is executing its "Joint 2.0" strategy to become a pure-play franchisor by selling its company-owned or managed clinics, having refranchised 41 clinics in 2025 and substantially completing the initiative in 2026. It is buying back regional developer territories to consolidate that network and repurchased 82,000 shares for $677,000 in Q2 2026. Management is investing in flexible membership options and national marketing to improve patient retention and comp trends. The stated priorities include share repurchases, RD territory buybacks, and margin improvement as a franchisor. New clinic openings by franchisees totaled five in Q2 2026, down from seven in Q2 2025.

Risks

• Labor shortage — A nationwide shortage of qualified chiropractors has limited new clinic openings and required higher wages, shorter hours, and increased operating expenses.
• Inflation and wage pressure — Inflation, particularly rising labor costs and minimum wage increases, has raised general and administrative expenses and reduced profitability at company-owned clinics.
• Discretionary nature of chiropractic care — Chiropractic services emphasize preventive and maintenance care, which is generally not a medical necessity and may be cut back when consumers reduce discretionary spending.
• Declining same-store sales — Comp sales declined 2.8% in Q2 2026 and system-wide sales fell 3.7% year over year, indicating pressure on the existing clinic base.

Outlook

Management expects the pure-play franchisor model to drive margin improvement, profitability, and continued free cash flow in the second half of 2026. The company ended Q2 2026 with $22.2 million in unrestricted cash and intends to continue share repurchases and regional developer territory buybacks. It is also investing in growth initiatives focused on patient retention and aligning offerings with consumer trends. No specific financial guidance figures were provided in the earnings release excerpt.